A higher possibility of finding viruses that cause Covid-19 was linked to patients who had taken the antiviral drugs.

There was also a 65% relative reduction in COVID-related medical visits (95% CI 24.4-83.8) with nirmatrelvir-ritonavir versus ...

Over the last few years, the SARS-CoV-2 virus, responsible for COVID-19, has undergone significant changes, evolving from the ...

Paxlovid significantly shortened the time to symptom relief (median, 13 vs 15 days; hazard ratio [HR], 1.27) and resolution (16 vs 19 days; HR, 1.20) through 28 days and cut the number of ...

COVID-19 antivirals, specifically, have become hard to access for some patients. Many requirements accompany the distribution of the drugs to patients, and for a good reason. Accessing antivirals ...

If you are at higher risk, you should speak with your doctor about getting a real diagnosis for the appropriate treatment.

COVID: Phase 1 pharmacokinetic profile supports the potential for ratutrelvir to be dosed as a once-a-day, single drug, 10-day treatment course, ...

Chatham-Kent health agencies urge the public to take advantage of the flu and COVID-19 vaccines and RSV (respiratory ...

Taking an antiviral medication for a year may prevent vision ... and whether the shingles vaccine affected COVID-19 diagnosis and severity among participants. Other principal study investigators ...

Phase III Scorpio-PEP study results showed Shionogi & Co. Ltd.’s oral antiviral ensitrelvir fumaric acid (Xocova) reduced risk of symptomatic COVID-19 infection in subjects who were exposed to the ...

Four antiviral drugs are available for the prevention and treatment of influenza infections: oseltamivir, zanamivir, rimantadine and amantadine. Oseltamivir and zanamivir are neuraminidase ...